| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.955 | 0.001 | 0.955 | Calcium antagonist | 0.583 0.002 CID_10003684 0.173 0.017 CID_252325 0.694 0.001 CID_173322 | ||
| 0.926 | 0.002 | 0.926 | Vasodilator, peripheral | 0.739 0.005 CID_10003684 0.422 0.049 CID_252325 0.829 0.003 CID_173322 | ||
| 0.919 | 0.002 | 0.919 | Calcium channel blocker | 0.787 0.003 CID_10003684 0.731 0.003 CID_173322 | ||
| 0.866 | 0.001 | 0.866 | Calcium channel L-type blocker | 0.653 0.002 CID_10003684 0.079 0.041 CID_252325 0.673 0.002 CID_173322 | ||
| 0.848 | 0.002 | 0.848 | Calcium channel (voltage-sensitive) blocker | 0.631 0.003 CID_10003684 0.537 0.004 CID_173322 | ||
| 0.842 | 0.003 | 0.842 | Vasodilator, coronary | 0.452 0.023 CID_10003684 0.388 0.039 CID_252325 0.821 0.004 CID_173322 | ||
| 0.7 | 0.004 | 0.7 | Vasodilator | 0.477 0.014 CID_10003684 0.451 0.016 CID_252325 0.691 0.004 CID_173322 | ||
| 0.696 | 0.003 | 0.717 | Calcium channel L-type activator | 0.692 0.003 CID_10003684 0.717 0.002 CID_173322 | CID_173322 | |
| 0.669 | 0.002 | 0.673 | Calcium channel activator | 0.57 0.003 CID_10003684 0.394 0.027 CID_252325 0.673 0.002 CID_173322 | CID_173322 | |
| 0.542 | 0.003 | 0.593 | TRPA1 agonist | 0.172 0.019 CID_10003684 0.248 0.005 CID_252325 0.593 0.003 CID_173322 | CID_173322 | |
| 0.504 | 0.044 | 0.534 | Transcription factor NF kappa B inhibitor | 0.407 0.062 CID_10003684 0.534 0.04 CID_252325 0.352 0.076 CID_173322 | CID_252325 | |
| 0.374 | 0.034 | 0.494 | Cardiotonic | 0.494 0.016 CID_173322 | CID_173322 | |
| 0.367 | 0.027 | 0.518 | Sigma receptor agonist | 0.389 0.024 CID_10003684 0.518 0.008 CID_252325 0.205 0.06 CID_173322 | CID_252325 | |
| 0.438 | 0.105 | 0.523 | DNA polymerase beta inhibitor | 0.523 0.08 CID_10003684 0.216 0.213 CID_252325 0.412 0.114 CID_173322 | CID_10003684 | |
| 0.373 | 0.057 | 0.373 | Antithrombotic | 0.216 0.158 CID_10003684 0.296 0.091 CID_252325 0.356 0.062 CID_173322 | ||
| 0.406 | 0.107 | 0.425 | Transcription factor inhibitor | 0.425 0.1 CID_10003684 0.348 0.131 CID_252325 0.286 0.163 CID_173322 | CID_10003684 | |
| 0.353 | 0.056 | 0.488 | 12-Lipoxygenase inhibitor | 0.488 0.023 CID_10003684 0.284 0.089 CID_252325 0.224 0.126 CID_173322 | CID_10003684 | |
| 0.324 | 0.033 | 0.448 | Cyclic AMP phosphodiesterase inhibitor | 0.161 0.134 CID_10003684 0.289 0.046 CID_252325 0.448 0.011 CID_173322 | CID_173322 | |
| 0.402 | 0.115 | 0.485 | DNA directed DNA polymerase inhibitor | 0.485 0.087 CID_10003684 0.251 0.191 CID_252325 0.372 0.128 CID_173322 | CID_10003684 | |
| 0.309 | 0.027 | 0.347 | P-glycoprotein inhibitor | 0.254 0.04 CID_10003684 0.347 0.022 CID_252325 0.211 0.058 CID_173322 | CID_252325 | |
| 0.304 | 0.027 | 0.304 | 5 Hydroxytryptamine 1E antagonist | 0.233 0.093 CID_10003684 0.297 0.031 CID_252325 0.284 0.041 CID_173322 | ||
| 0.306 | 0.034 | 0.306 | Platelet aggregation inhibitor | 0.298 0.036 CID_173322 | ||
| 0.275 | 0.006 | 0.308 | Neuropeptide Y1 antagonist | 0.219 0.013 CID_10003684 0.129 0.103 CID_252325 0.308 0.005 CID_173322 | CID_173322 | |
| 0.314 | 0.048 | 0.314 | Platelet antagonist | 0.148 0.147 CID_10003684 0.271 0.064 CID_252325 0.285 0.058 CID_173322 | ||
| 0.36 | 0.094 | 0.369 | 15-Lipoxygenase inhibitor | 0.369 0.089 CID_10003684 0.346 0.102 CID_252325 0.234 0.178 CID_173322 | CID_10003684 | |
| 0.335 | 0.083 | 0.335 | Thioredoxin glutathione reductase inhibitor | 0.33 0.086 CID_10003684 0.205 0.168 CID_252325 0.276 0.117 CID_173322 | ||
| 0.256 | 0.009 | 0.41 | Adenylate kinase inhibitor | 0.118 0.045 CID_10003684 0.181 0.018 CID_252325 0.41 0.003 CID_173322 | CID_173322 | |
| 0.268 | 0.023 | 0.421 | NOS3 expression enhancer | 0.287 0.02 CID_10003684 0.421 0.007 CID_252325 0.161 0.062 CID_173322 | CID_252325 | |
| 0.318 | 0.074 | 0.519 | Apoptosis antagonist | 0.287 0.095 CID_10003684 0.519 0.018 CID_252325 0.244 0.134 CID_173322 | CID_252325 | |
| 0.365 | 0.131 | 0.718 | Apoptosis agonist | 0.425 0.102 CID_10003684 0.718 0.028 CID_252325 | CID_252325 | |
| 0.288 | 0.055 | 0.521 | Free radical scavenger | 0.277 0.058 CID_10003684 0.521 0.014 CID_252325 0.201 0.097 CID_173322 | CID_252325 | |
| 0.254 | 0.031 | 0.261 | Amyloid beta precursor protein antagonist | 0.261 0.029 CID_10003684 0.227 0.042 CID_252325 0.167 0.084 CID_173322 | CID_10003684 | |
| 0.231 | 0.013 | 0.231 | Alpha 2c adrenoreceptor antagonist | 0.137 0.039 CID_10003684 0.094 0.071 CID_252325 0.178 0.023 CID_173322 | ||
| 0.268 | 0.075 | 0.572 | Antioxidant | 0.245 0.087 CID_10003684 0.572 0.013 CID_252325 0.186 0.126 CID_173322 | CID_252325 | |
| 0.205 | 0.016 | 0.205 | Ca(v)2.2 blocker | 0.101 0.047 CID_10003684 | ||
| 0.207 | 0.018 | 0.289 | CF transmembrane conductance regulator agonist | 0.155 0.068 CID_252325 0.289 0.004 CID_173322 | CID_173322 | |
| 0.206 | 0.022 | 0.236 | Alpha 2b adrenoreceptor antagonist | 0.11 0.066 CID_10003684 0.236 0.017 CID_173322 | CID_173322 | |
| 0.325 | 0.168 | 0.59 | Caspase 9 stimulant | 0.505 0.058 CID_10003684 0.59 0.038 CID_252325 0.307 0.186 CID_173322 | CID_252325 | |
| 0.237 | 0.088 | 0.463 | DNA damaging | 0.463 0.018 CID_10003684 0.348 0.041 CID_252325 | CID_10003684 | |
| 0.249 | 0.101 | 0.418 | Lipoxygenase inhibitor | 0.418 0.033 CID_10003684 0.357 0.049 CID_252325 | CID_10003684 | |
| 0.285 | 0.147 | 0.412 | Antibacterial | 0.314 0.125 CID_10003684 0.412 0.072 CID_252325 0.32 0.12 CID_173322 | CID_252325 | |
| 0.231 | 0.1 | 0.372 | Transcription factor STAT3 inhibitor | 0.372 0.026 CID_252325 0.264 0.073 CID_173322 | CID_252325 | |
| 0.154 | 0.023 | 0.154 | Beta glucuronidase inhibitor | 0.143 0.028 CID_10003684 0.132 0.035 CID_252325 0.129 0.038 CID_173322 | ||
| 0.191 | 0.062 | 0.249 | Lipocortins synthesis antagonist | 0.249 0.034 CID_173322 | CID_173322 | |
| 0.15 | 0.021 | 0.157 | Toll-Like receptor 4 antagonist | 0.157 0.017 CID_10003684 0.157 0.018 CID_252325 0.121 0.043 CID_173322 | CID_252325 | |
| 0.194 | 0.069 | 0.331 | Hepatoprotectant | 0.134 0.128 CID_10003684 0.331 0.022 CID_252325 0.185 0.075 CID_173322 | CID_252325 | |
| 0.242 | 0.119 | 0.25 | Caspase 3 stimulant | 0.25 0.113 CID_10003684 0.243 0.118 CID_252325 | CID_10003684 | |
| 0.133 | 0.017 | 0.139 | Glutathione S-transferase inhibitor | 0.137 0.015 CID_10003684 0.139 0.015 CID_252325 0.092 0.045 CID_173322 | CID_252325 | |
| 0.151 | 0.037 | 0.154 | Calcium channel N-type blocker | 0.154 0.035 CID_10003684 0.115 0.07 CID_252325 | CID_10003684 | |
| 0.219 | 0.106 | 0.264 | Spasmolytic | 0.264 0.085 CID_252325 0.214 0.109 CID_173322 | CID_252325 | |
| 0.152 | 0.045 | 0.19 | Alkylator | 0.19 0.029 CID_10003684 0.161 0.041 CID_252325 0.146 0.049 CID_173322 | CID_10003684 | |
| 0.121 | 0.017 | 0.121 | Histone deacetylase SIRT1 stimulant | 0.088 0.036 CID_252325 0.074 0.05 CID_173322 | ||
| 0.121 | 0.017 | 0.121 | Histone deacetylase stimulant | 0.088 0.036 CID_252325 0.074 0.05 CID_173322 | ||
| 0.145 | 0.044 | 0.797 | Interleukin 1b antagonist | 0.151 0.04 CID_10003684 0.797 0.003 CID_252325 | CID_252325 | |
| 0.184 | 0.084 | 0.276 | Non-steroidal antiinflammatory agent | 0.211 0.062 CID_10003684 0.276 0.034 CID_252325 0.257 0.04 CID_173322 | CID_252325 | |
| 0.131 | 0.032 | 0.282 | Breast cancer-resistant protein inhibitor | 0.282 0.008 CID_10003684 0.175 0.017 CID_252325 0.094 0.062 CID_173322 | CID_10003684 | |
| 0.272 | 0.175 | 0.354 | Alpha-glucosidase inhibitor | 0.354 0.134 CID_10003684 0.253 0.186 CID_252325 0.313 0.153 CID_173322 | CID_10003684 | |
| 0.117 | 0.022 | 0.131 | Bile acid receptor antagonist | 0.1 0.05 CID_252325 0.131 0.013 CID_173322 | CID_173322 | |
| 0.146 | 0.056 | 0.186 | Farnesoid X receptor antagonist | 0.186 0.027 CID_173322 | CID_173322 | |
| 0.119 | 0.034 | 0.195 | Androgen antagonist | 0.109 0.04 CID_252325 0.195 0.014 CID_173322 | CID_173322 | |
| 0.108 | 0.023 | 0.173 | Thioredoxin reductase inhibitor | 0.134 0.013 CID_10003684 0.173 0.006 CID_252325 0.087 0.047 CID_173322 | CID_252325 | |
| 0.091 | 0.008 | 0.091 | Thromboxane synthase inhibitor | 0.07 0.017 CID_10003684 0.056 0.035 CID_252325 0.091 0.008 CID_173322 | ||
| 0.093 | 0.013 | 0.093 | Nitric oxide donor | 0.081 0.022 CID_10003684 0.077 0.025 CID_173322 | ||
| 0.088 | 0.009 | 0.133 | Mineralocorticoid receptor antagonist | 0.133 0.005 CID_173322 | CID_173322 | |
| 0.144 | 0.081 | 0.184 | Phospholipase A2 inhibitor | 0.119 0.118 CID_10003684 0.171 0.059 CID_252325 0.184 0.052 CID_173322 | CID_173322 | |
| 0.146 | 0.083 | 0.279 | Interferon gamma antagonist | 0.146 0.083 CID_10003684 0.279 0.023 CID_252325 0.163 0.063 CID_173322 | CID_252325 | |
| 0.139 | 0.078 | 0.183 | Heat shock protein 70 antagonist | 0.14 0.077 CID_10003684 0.183 0.01 CID_252325 0.149 0.048 CID_173322 | CID_252325 | |
| 0.132 | 0.074 | 0.785 | Interleukin 1 antagonist | 0.212 0.028 CID_10003684 0.785 0.003 CID_252325 | CID_252325 | |
| 0.102 | 0.046 | 0.16 | Thioredoxin inhibitor | 0.104 0.044 CID_10003684 0.16 0.014 CID_252325 0.081 0.08 CID_173322 | CID_252325 | |
| 0.075 | 0.021 | 0.116 | Potassium channel intermediate-conductance Ca-activated blocker | 0.057 0.049 CID_252325 0.116 0.005 CID_173322 | CID_173322 | |
| 0.065 | 0.013 | 0.065 | Progesterone antagonist | 0.037 0.024 CID_252325 0.064 0.013 CID_173322 | ||
| 0.066 | 0.016 | 0.176 | Aldosterone antagonist | 0.176 0.004 CID_173322 | CID_173322 | |
| 0.18 | 0.129 | 0.222 | Peptidyltransferase inhibitor | 0.222 0.074 CID_252325 0.191 0.111 CID_173322 | CID_252325 | |
| 0.142 | 0.093 | 0.398 | Melanin inhibitor | 0.149 0.083 CID_10003684 0.398 0.012 CID_252325 | CID_252325 | |
| 0.221 | 0.172 | 0.24 | Beta lactamase inhibitor | 0.24 0.161 CID_10003684 | CID_10003684 | |
| 0.141 | 0.099 | 0.195 | Mcl-1 antagonist | 0.195 0.058 CID_10003684 0.189 0.062 CID_173322 | CID_10003684 | |
| 0.201 | 0.164 | 0.409 | Cholesterol antagonist | 0.255 0.121 CID_10003684 0.409 0.047 CID_252325 0.324 0.077 CID_173322 | CID_252325 | |
| 0.098 | 0.061 | 0.17 | Xanthine oxidase inhibitor | 0.17 0.028 CID_10003684 0.145 0.036 CID_252325 0.141 0.038 CID_173322 | CID_10003684 | |
| 0.163 | 0.128 | 0.316 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.223 0.088 CID_10003684 0.203 0.098 CID_252325 0.316 0.06 CID_173322 | CID_173322 | |
| 0.079 | 0.045 | 0.086 | Adenosine A3 receptor antagonist | 0.086 0.036 CID_173322 | CID_173322 | |
| 0.193 | 0.16 | 0.287 | Hypoxia-inducible factor 1 alpha inhibitor | 0.183 0.175 CID_10003684 0.284 0.074 CID_252325 0.287 0.072 CID_173322 | CID_173322 | |
| 0.139 | 0.106 | 0.522 | Nitric oxide antagonist | 0.136 0.111 CID_10003684 0.522 0.014 CID_252325 | CID_252325 | |
| 0.143 | 0.112 | 0.283 | DNA methyltransferase I inhibitor | 0.229 0.056 CID_10003684 0.283 0.033 CID_252325 0.142 0.112 CID_173322 | CID_252325 | |
| 0.1 | 0.07 | 0.124 | Mediator release inhibitor | 0.113 0.054 CID_252325 0.124 0.044 CID_173322 | CID_173322 | |
| 0.088 | 0.058 | 0.123 | Interleukin 5 antagonist | 0.116 0.027 CID_10003684 0.123 0.022 CID_252325 0.093 0.05 CID_173322 | CID_252325 | |
| 0.146 | 0.118 | 0.467 | Anesthetic general | 0.187 0.082 CID_10003684 0.467 0.01 CID_252325 0.214 0.067 CID_173322 | CID_252325 | |
| 0.129 | 0.102 | 0.163 | Pregnane X receptor agonist | 0.163 0.034 CID_252325 0.14 0.074 CID_173322 | CID_252325 | |
| 0.08 | 0.057 | 0.137 | Glycine receptor antagonist | 0.119 0.018 CID_252325 0.137 0.011 CID_173322 | CID_173322 | |
| 0.111 | 0.09 | 0.17 | Sphingosine 1-phosphate receptor 4 antagonist | 0.112 0.089 CID_10003684 0.17 0.019 CID_252325 0.136 0.048 CID_173322 | CID_252325 | |
| 0.036 | 0.017 | 0.043 | Transforming growth factor beta 2 antagonist | 0.043 0.01 CID_173322 | CID_173322 | |
| 0.103 | 0.088 | 0.128 | M18 aspartyl aminopeptidase inhibitor | 0.128 0.065 CID_10003684 0.112 0.078 CID_252325 0.118 0.072 CID_173322 | CID_10003684 | |
| 0.06 | 0.046 | 0.109 | Heme oxygenase stimulant | 0.061 0.042 CID_10003684 0.109 0.005 CID_252325 | CID_252325 | |
| 0.118 | 0.107 | 0.273 | Diuretic | 0.273 0.027 CID_173322 | CID_173322 | |
| 0.051 | 0.041 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | 0.061 0.025 CID_252325 0.06 0.027 CID_173322 | CID_252325 | |
| 0.027 | 0.019 | 0.054 | NMDA 2D receptor antagonist | 0.035 0.012 CID_10003684 0.029 0.017 CID_252325 0.054 0.006 CID_173322 | CID_173322 | |
| 0.167 | 0.16 | 0.586 | Superoxide dismutase inhibitor | 0.196 0.122 CID_10003684 0.586 0.007 CID_252325 0.228 0.091 CID_173322 | CID_252325 | |
| 0.104 | 0.097 | 0.295 | Tubulin antagonist | 0.295 0.02 CID_252325 | CID_252325 | |
| 0.06 | 0.055 | 0.093 | Beta adrenoreceptor antagonist | 0.059 0.058 CID_252325 0.093 0.019 CID_173322 | CID_173322 | |
| 0.043 | 0.04 | 0.043 | Dopamine transporter inhibitor | |||
| 0.067 | 0.064 | 0.148 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.082 0.049 CID_10003684 0.148 0.019 CID_252325 0.081 0.05 CID_173322 | CID_252325 | |
| 0.079 | 0.078 | 0.108 | Potassium channel activator | 0.1 0.048 CID_252325 0.108 0.041 CID_173322 | CID_173322 | |
| 0.065 | 0.065 | 0.076 | Alpha 2a adrenoreceptor antagonist | 0.076 0.052 CID_173322 | CID_173322 | |
| 0.054 | 0.058 | 0.104 | Transcription factor AP-1 inhibitor | 0.059 0.046 CID_10003684 0.104 0.012 CID_252325 | CID_252325 | |
| 0.131 | 0.135 | 0.136 | Angiogenesis stimulant | 0.136 0.131 CID_252325 | CID_252325 | |
| 0.044 | 0.049 | 0.082 | Thromboxane antagonist | 0.082 0.019 CID_173322 | CID_173322 | |
| 0.035 | 0.042 | 0.117 | Phosphorylase inhibitor | 0.117 0.01 CID_173322 | CID_173322 | |
| 0.135 | 0.143 | 0.338 | Succinate dehydrogenase inhibitor | 0.159 0.096 CID_10003684 0.338 0.006 CID_252325 0.201 0.048 CID_173322 | CID_252325 | |
| 0.108 | 0.116 | 0.242 | Cytidine deaminase inhibitor | 0.203 0.046 CID_10003684 0.242 0.032 CID_252325 0.153 0.073 CID_173322 | CID_252325 | |
| 0.027 | 0.036 | 0.035 | Catechol O-methyltransferase inhibitor | 0.035 0.019 CID_10003684 0.03 0.027 CID_173322 | CID_10003684 | |
| 0.088 | 0.097 | 0.299 | Anesthetic local | 0.299 0.013 CID_10003684 0.226 0.025 CID_252325 | CID_10003684 | |
| 0.023 | 0.033 | 0.027 | Plasmepsin I inhibitor | 0.027 0.025 CID_10003684 | CID_10003684 | |
| 0.079 | 0.09 | 0.103 | ABCA1 expression enhancer | 0.084 0.077 CID_252325 0.103 0.046 CID_173322 | CID_173322 | |
| 0.098 | 0.111 | 0.236 | Cathepsin H inhibitor | 0.114 0.083 CID_10003684 0.236 0.015 CID_252325 0.116 0.08 CID_173322 | CID_252325 | |
| 0.075 | 0.088 | 0.086 | 3C-Like protease (SARS coronavirus) inhibitor | 0.086 0.054 CID_252325 | CID_252325 | |
| 0.043 | 0.057 | 0.071 | Beta 1 adrenoreceptor antagonist | 0.062 0.034 CID_252325 0.071 0.025 CID_173322 | CID_173322 | |
| 0.048 | 0.062 | 0.069 | Botulinum neurotoxin type A inhibitor | 0.069 0.026 CID_252325 | CID_252325 | |
| 0.036 | 0.05 | 0.075 | Thromboxane A2 antagonist | 0.075 0.018 CID_173322 | CID_173322 | |
| 0.064 | 0.08 | 0.187 | Keratolytic | 0.187 0.009 CID_252325 0.078 0.052 CID_173322 | CID_252325 | |
| 0.042 | 0.058 | 0.118 | Alpha 1d adrenoreceptor antagonist | 0.118 0.019 CID_173322 | CID_173322 | |
| 0.052 | 0.069 | 0.129 | Alpha 1b adrenoreceptor antagonist | 0.129 0.027 CID_173322 | CID_173322 | |
| 0.08 | 0.103 | 0.129 | Protein-tyrosine phosphatase 1B inhibitor | 0.129 0.056 CID_252325 | CID_252325 | |
| 0.066 | 0.09 | 0.086 | Neuropeptide Y antagonist | 0.086 0.051 CID_173322 | CID_173322 | |
| 0.014 | 0.038 | 0.042 | NMDA receptor glycine site antagonist | 0.042 0.008 CID_173322 | CID_173322 | |
| 0.107 | 0.131 | 0.142 | Protein-tyrosine phosphatase inhibitor | 0.127 0.105 CID_10003684 0.142 0.087 CID_252325 0.131 0.1 CID_173322 | CID_252325 | |
| 0.069 | 0.096 | 0.327 | 5-Lipoxygenase inhibitor | 0.213 0.022 CID_10003684 0.327 0.008 CID_252325 | CID_252325 | |
| 0.097 | 0.127 | 0.264 | Protein kinase stimulant | 0.264 0.023 CID_252325 | CID_252325 | |
| 0.016 | 0.046 | 0.032 | Retinoic acid gamma receptor agonist | 0.032 0.005 CID_252325 | CID_252325 | |
| 0.084 | 0.115 | 0.263 | Amylase inhibitor | 0.263 0.025 CID_252325 0.101 0.095 CID_173322 | CID_252325 | |
| 0.015 | 0.047 | 0.034 | Retinoic acid receptor agonist | 0.034 0.008 CID_252325 | CID_252325 | |
| 0.06 | 0.092 | 0.145 | Ornithine decarboxylase inhibitor | 0.145 0.013 CID_252325 | CID_252325 | |
| 0.042 | 0.075 | 0.111 | TRPA1 antagonist | 0.111 0.015 CID_252325 | CID_252325 | |
| 0.028 | 0.063 | 0.058 | Retinoic acid alpha receptor agonist | 0.058 0.01 CID_252325 0.038 0.028 CID_173322 | CID_252325 | |
| 0.036 | 0.072 | 0.062 | Potassium channel (ATP-sensitive) activator | 0.062 0.015 CID_173322 | CID_173322 | |
| 0.038 | 0.074 | 0.065 | Potassium channel (Inward rectifier) activator | 0.065 0.015 CID_173322 | CID_173322 | |
| 0.144 | 0.181 | 0.229 | Streptokinase A inhibitor | 0.229 0.116 CID_10003684 0.181 0.146 CID_173322 | CID_10003684 | |
| 0.164 | 0.202 | 0.38 | Transcription factor STAT inhibitor | 0.38 0.024 CID_252325 0.199 0.14 CID_173322 | CID_252325 | |
| 0.116 | 0.154 | 0.169 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.169 0.043 CID_173322 | CID_173322 | |
| 0.028 | 0.068 | 0.066 | Glutamate (mGluR8) agonist | 0.044 0.016 CID_252325 0.066 0.005 CID_173322 | CID_173322 | |
| 0.052 | 0.094 | 0.091 | Transcription factor RelA inhibitor | 0.063 0.045 CID_10003684 0.091 0.01 CID_252325 | CID_252325 | |
| 0.101 | 0.145 | 0.2 | Mannose-6-phosphate isomerase inhibitor | 0.142 0.072 CID_10003684 0.181 0.042 CID_252325 0.2 0.031 CID_173322 | CID_173322 | |
| 0.039 | 0.084 | 0.099 | Factor III inhibitor | 0.099 0.005 CID_252325 | CID_252325 | |
| 0.081 | 0.128 | 0.192 | Microtubule formation inhibitor | 0.192 0.022 CID_252325 | CID_252325 | |
| 0.057 | 0.104 | 0.078 | Alpha 2 adrenoreceptor antagonist | 0.078 0.068 CID_252325 | CID_252325 | |
| 0.104 | 0.153 | 0.458 | Amyloid beta aggregation inhibitor | 0.131 0.124 CID_10003684 0.458 0.018 CID_252325 | CID_252325 | |
| 0.057 | 0.107 | 0.082 | Antiadrenergic | 0.082 0.069 CID_173322 | CID_173322 | |
| 0.035 | 0.086 | 0.107 | NMDA receptor glycine site agonist | 0.107 0.013 CID_252325 0.07 0.036 CID_173322 | CID_252325 | |
| 0.041 | 0.091 | 0.116 | HIV-1 integrase (3'-Processing) inhibitor | 0.056 0.052 CID_10003684 0.116 0.021 CID_252325 | CID_252325 | |
| 0.054 | 0.105 | 0.08 | Adrenaline antagonist | 0.08 0.068 CID_173322 | CID_173322 | |
| 0.082 | 0.134 | 0.141 | Photosensitizer | 0.099 0.09 CID_10003684 0.141 0.037 CID_252325 0.123 0.053 CID_173322 | CID_252325 | |
| 0.021 | 0.074 | 0.032 | Purinergic P2Y2 antagonist | 0.032 0.026 CID_173322 | CID_173322 | |
| 0.037 | 0.091 | 0.063 | CD45 antagonist | 0.046 0.045 CID_252325 0.063 0.019 CID_173322 | CID_173322 | |
| 0.005 | 0.059 | 0.014 | Human herpes virus 5 capsid protein P40 inhibitor | 0.014 0.007 CID_252325 | CID_252325 | |
| 0.001 | 0.055 | 0.004 | Human herpesvirus 2 protease inhibitor | 0.004 0.002 CID_252325 | CID_252325 | |
| 0.029 | 0.086 | 0.104 | Kainate receptor agonist | 0.104 0.003 CID_252325 0.038 0.037 CID_173322 | CID_252325 | |
| 0.051 | 0.109 | 0.144 | GABA aminotransferase inhibitor | 0.144 0.009 CID_252325 0.105 0.024 CID_173322 | CID_252325 | |
| 0.012 | 0.069 | 0.022 | Retinoic acid beta receptor agonist | 0.022 0.01 CID_252325 | CID_252325 | |
| 0.031 | 0.092 | 0.068 | Dopamine uptake inhibitor | 0.068 0.032 CID_252325 | CID_252325 | |
| 0.017 | 0.079 | 0.066 | Kainate receptor antagonist | 0.066 0.014 CID_252325 0.051 0.02 CID_173322 | CID_252325 | |
| 0.007 | 0.069 | 0.017 | Thromboxane A2 agonist | 0.017 0.009 CID_252325 | CID_252325 | |
| 0.074 | 0.137 | 0.105 | Multidrug resistance-associated protein 1 inhibitor | 0.105 0.07 CID_10003684 0.1 0.078 CID_173322 | CID_10003684 | |
| 0.034 | 0.098 | 0.105 | Glucose-6-phosphate translocase inhibitor | 0.105 0.005 CID_252325 | CID_252325 | |
| 0.144 | 0.207 | 0.268 | Prostaglandin dehydrogenase inhibitor | 0.268 0.118 CID_10003684 0.262 0.121 CID_252325 | CID_10003684 | |
| 0.079 | 0.143 | 0.123 | Acetylcholinesterase inhibitor | 0.123 0.075 CID_252325 | CID_252325 | |
| 0.103 | 0.169 | 0.235 | GABA C receptor rho-2 antagonist | 0.143 0.084 CID_10003684 0.235 0.015 CID_252325 0.136 0.094 CID_173322 | CID_252325 | |
| 0.106 | 0.176 | 0.324 | Aryl hydrocarbon receptor agonist | 0.324 0.054 CID_10003684 0.181 0.114 CID_252325 0.201 0.102 CID_173322 | CID_10003684 | |
| 0.079 | 0.151 | 0.171 | Lipid peroxidase inhibitor | 0.171 0.055 CID_252325 | CID_252325 | |
| 0.015 | 0.088 | 0.04 | Farnesoid X receptor agonist | 0.04 0.023 CID_252325 | CID_252325 | |
| 0.024 | 0.099 | 0.055 | Dihydroorotase inhibitor | 0.051 0.023 CID_252325 0.055 0.02 CID_173322 | CID_173322 | |
| 0.029 | 0.104 | 0.087 | Glutamate (mGluR group III) antagonist | 0.087 0.006 CID_173322 | CID_173322 | |
| 0.012 | 0.088 | 0.085 | Kainate receptor 2 antagonist | 0.085 0.005 CID_252325 | CID_252325 | |
| 0.023 | 0.099 | 0.096 | Aromatase inhibitor | 0.096 0.022 CID_252325 | CID_252325 | |
| 0.009 | 0.085 | 0.023 | Retinoid X gamma receptor agonist | 0.023 0.016 CID_252325 | CID_252325 | |
| 0.017 | 0.093 | 0.043 | Carbonic anhydrase VII inhibitor | 0.043 0.036 CID_252325 | CID_252325 | |
| 0.008 | 0.083 | 0.03 | Retinoic acid alpha receptor antagonist | 0.03 0.007 CID_252325 | CID_252325 | |
| 0.022 | 0.099 | 0.136 | Beta tubulin antagonist | 0.136 0.014 CID_252325 | CID_252325 | |
| 0.007 | 0.084 | 0.025 | Retinoic acid receptor antagonist | 0.025 0.007 CID_252325 | CID_252325 | |
| 0.024 | 0.101 | 0.054 | Carbonic anhydrase XIV inhibitor | 0.054 0.029 CID_252325 | CID_252325 | |
| 0.015 | 0.094 | 0.036 | Retinoid X gamma receptor antagonist | 0.036 0.006 CID_252325 | CID_252325 | |
| 0.037 | 0.121 | 0.139 | Carbonic anhydrase XIII inhibitor | 0.139 0.024 CID_252325 | CID_252325 | |
| 0.031 | 0.118 | 0.103 | Squalene epoxidase inhibitor | 0.103 0.005 CID_252325 | CID_252325 | |
| 0.004 | 0.091 | 0.021 | Immunosuppressant Cyclosporine-like | 0.021 0.003 CID_252325 | CID_252325 | |
| 0.027 | 0.115 | 0.078 | HIV-1 integrase (Strand Transfer) inhibitor | 0.078 0.032 CID_252325 | CID_252325 | |
| 0.035 | 0.124 | 0.191 | Histidine decarboxylase inhibitor | 0.104 0.03 CID_252325 0.191 0.014 CID_173322 | CID_173322 | |
| 0.008 | 0.097 | 0.02 | Retinoid X beta receptor agonist | 0.02 0.016 CID_252325 | CID_252325 | |
| 0.073 | 0.162 | 0.146 | M17 leucyl aminopeptidase inhibitor | 0.146 0.058 CID_173322 | CID_173322 | |
| 0.079 | 0.168 | 0.14 | Interleukin 4 antagonist | 0.13 0.072 CID_10003684 0.14 0.059 CID_252325 0.136 0.064 CID_173322 | CID_252325 | |
| 0.052 | 0.143 | 0.075 | MDM2 inhibitor | 0.075 0.027 CID_252325 0.075 0.027 CID_173322 | CID_173322 | |
| 0.004 | 0.096 | 0.037 | Kainate receptor 1 antagonist | 0.037 0.008 CID_252325 | CID_252325 | |
| 0.071 | 0.164 | 0.163 | DOPA decarboxylase inhibitor | 0.095 0.087 CID_10003684 0.13 0.035 CID_252325 0.163 0.015 CID_173322 | CID_173322 | |
| 0.022 | 0.117 | 0.063 | Glutamate (mGluR1) antagonist | 0.063 0.036 CID_173322 | CID_173322 | |
| 0.02 | 0.116 | 0.044 | Fructose-1,6-bisphosphatase inhibitor | 0.044 0.032 CID_252325 0.041 0.037 CID_173322 | CID_252325 | |
| 0.005 | 0.101 | 0.012 | Retinoic acid receptor gamma antagonist | 0.012 0.008 CID_252325 | CID_252325 | |
| 0.099 | 0.196 | 0.264 | DNA methylase inhibitor | 0.16 0.109 CID_10003684 0.264 0.041 CID_252325 | CID_252325 | |
| 0.003 | 0.101 | 0.01 | Thromboxane agonist | 0.01 0.008 CID_252325 | CID_252325 | |
| 0.071 | 0.171 | 0.154 | Cyclooxygenase 3 inhibitor | 0.154 0.045 CID_252325 | CID_252325 | |
| 0.02 | 0.121 | 0.091 | Dihydroorotate dehydrogenase inhibitor | 0.091 0.014 CID_173322 | CID_173322 | |
| 0.046 | 0.147 | 0.084 | Glutamate (mGluR6) antagonist | 0.084 0.02 CID_252325 0.08 0.024 CID_173322 | CID_252325 | |
| 0.035 | 0.138 | 0.134 | NMDA receptor agonist | 0.134 0.01 CID_252325 0.06 0.047 CID_173322 | CID_252325 | |
| 0.075 | 0.178 | 0.127 | Toll-Like receptor antagonist | 0.127 0.075 CID_10003684 0.108 0.105 CID_252325 | CID_10003684 | |
| 0.004 | 0.108 | 0.012 | Retinoic acid beta receptor antagonist | 0.012 0.008 CID_252325 | CID_252325 | |
| 0.031 | 0.136 | 0.066 | Leukotriene synthesis inhibitor | 0.066 0.048 CID_10003684 | CID_10003684 | |
| 0.104 | 0.21 | 0.371 | Interleukin agonist | 0.371 0.024 CID_252325 0.164 0.154 CID_173322 | CID_252325 | |
| 0.07 | 0.178 | 0.133 | Toll-Like receptor 9 antagonist | 0.133 0.074 CID_252325 | CID_252325 | |
| 0.026 | 0.134 | 0.072 | Glutamate (mGluR4) antagonist | 0.072 0.01 CID_173322 | CID_173322 | |
| 0.014 | 0.122 | 0.034 | NMDA receptor subunit 3A antagonist | 0.034 0.031 CID_173322 | CID_173322 | |
| 0.107 | 0.216 | 0.28 | ATPase inhibitor | 0.28 0.008 CID_252325 | CID_252325 | |
| 0.104 | 0.213 | 0.2 | Immunostimulant | 0.2 0.12 CID_252325 | CID_252325 | |
| 0.008 | 0.118 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.022 0.02 CID_252325 | CID_252325 | |
| 0.025 | 0.136 | 0.15 | Biliverdin reductase inhibitor | 0.15 0.009 CID_252325 0.102 0.018 CID_173322 | CID_252325 | |
| 0.01 | 0.121 | 0.04 | Retinoid X beta receptor antagonist | 0.04 0.003 CID_252325 | CID_252325 | |
| 0.023 | 0.133 | 0.034 | Calcium-independent phospholipase A2 inhibitor | 0.034 0.025 CID_252325 | CID_252325 | |
| 0.088 | 0.199 | 0.151 | Thiol protease inhibitor | 0.151 0.068 CID_252325 | CID_252325 | |
| 0.009 | 0.122 | 0.08 | Retinoid X receptor agonist | 0.031 0.029 CID_10003684 0.08 0.008 CID_252325 | CID_252325 | |
| 0.109 | 0.222 | 0.25 | Phospholipase C inhibitor | 0.25 0.025 CID_252325 0.149 0.108 CID_173322 | CID_252325 | |
| 0.029 | 0.144 | 0.105 | Sphingosine 1-phosphate receptor 4 agonist | 0.066 0.048 CID_10003684 0.105 0.023 CID_252325 | CID_252325 | |
| 0.019 | 0.135 | 0.044 | NMDA receptor subunit 3B antagonist | 0.044 0.03 CID_173322 | CID_173322 | |
| 0.069 | 0.186 | 0.173 | Toll-Like receptor 2 antagonist | 0.173 0.038 CID_252325 | CID_252325 | |
| 0.022 | 0.14 | 0.239 | Neuraminidase inhibitor | 0.239 0.004 CID_252325 | CID_252325 | |
| 0.111 | 0.23 | 0.147 | Death-associated protein kinase 2 inhibitor | 0.147 0.114 CID_173322 | CID_173322 | |
| 0.119 | 0.238 | 0.245 | Hypoglycemic | 0.244 0.08 CID_10003684 0.245 0.079 CID_252325 | CID_252325 | |
| 0.113 | 0.232 | 0.255 | Catenin beta inhibitor | 0.255 0.01 CID_252325 0.157 0.09 CID_173322 | CID_252325 | |
| 0.027 | 0.147 | 0.121 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.121 0.012 CID_252325 | CID_252325 | |
| 0.033 | 0.154 | 0.071 | Elastase 1 inhibitor | 0.071 0.045 CID_252325 | CID_252325 | |
| 0.018 | 0.139 | 0.06 | Xanthine dehydrogenase inhibitor | 0.06 0.038 CID_252325 | CID_252325 | |
| 0.016 | 0.139 | 0.08 | Potassium channel Kv1.3 blocker | 0.08 0.012 CID_252325 | CID_252325 | |
| 0.007 | 0.131 | 0.035 | Kynurenine 3 monooxygenase inhibitor | 0.035 0.012 CID_173322 | CID_173322 | |
| 0.075 | 0.198 | 0.336 | Psychostimulant | 0.336 0.034 CID_252325 0.153 0.113 CID_173322 | CID_252325 | |
| 0.005 | 0.131 | 0.018 | Integrin alphaLbeta2 antagonist | 0.018 0.005 CID_252325 | CID_252325 | |
| 0.043 | 0.17 | 0.168 | Carbonic anhydrase VI inhibitor | 0.168 0.017 CID_252325 | CID_252325 | |
| 0.086 | 0.212 | 0.225 | Platelet adhesion inhibitor | 0.208 0.067 CID_10003684 0.225 0.059 CID_252325 | CID_252325 | |
| 0.055 | 0.182 | 0.184 | Carbonic anhydrase III inhibitor | 0.184 0.019 CID_252325 0.091 0.073 CID_173322 | CID_252325 | |
| 0.03 | 0.157 | 0.235 | Neuraminidase (influenza) inhibitor | 0.235 0.004 CID_252325 | CID_252325 | |
| 0.09 | 0.218 | 0.349 | Antimitotic | 0.349 0.032 CID_252325 | CID_252325 | |
| 0.063 | 0.192 | 0.117 | Alkaline phosphatase inhibitor | 0.117 0.09 CID_10003684 0.111 0.099 CID_252325 0.117 0.09 CID_173322 | CID_173322 | |
| 0.078 | 0.209 | 0.15 | Dual specificity phosphatase 3 inhibitor | 0.149 0.097 CID_10003684 0.15 0.096 CID_173322 | CID_173322 | |
| 0.11 | 0.241 | 0.182 | Neurotensin receptor agonist | 0.182 0.048 CID_252325 0.151 0.098 CID_173322 | CID_252325 | |
| 0.13 | 0.265 | 0.205 | Calpain 2 inhibitor | 0.2 0.187 CID_252325 0.205 0.183 CID_173322 | CID_173322 | |
| 0.015 | 0.15 | 0.071 | GABA uptake inhibitor | 0.071 0.007 CID_252325 | CID_252325 | |
| 0.036 | 0.172 | 0.078 | NMDA receptor antagonist | 0.078 0.068 CID_173322 | CID_173322 | |
| 0.035 | 0.171 | 0.131 | MAO A inhibitor | 0.131 0.048 CID_252325 | CID_252325 | |
| 0.011 | 0.149 | 0.082 | Retinoid X alpha receptor agonist | 0.082 0.007 CID_252325 | CID_252325 | |
| 0.045 | 0.182 | 0.174 | MAO inhibitor | 0.174 0.05 CID_252325 | CID_252325 | |
| 0.01 | 0.148 | 0.062 | Nicotinic acid receptor agonist | 0.062 0.01 CID_252325 0.037 0.024 CID_173322 | CID_252325 | |
| 0.055 | 0.193 | 0.119 | Granulocyte macrophage colony stimulating factor agonist | 0.119 0.016 CID_252325 | CID_252325 | |
| 0.028 | 0.167 | 0.141 | MAO B inhibitor | 0.141 0.04 CID_252325 | CID_252325 | |
| 0.031 | 0.17 | 0.079 | DNA gyrase inhibitor | 0.079 0.027 CID_173322 | CID_173322 | |
| 0.011 | 0.151 | 0.065 | HMG CoA reductase inhibitor | 0.065 0.004 CID_252325 | CID_252325 | |
| 0.01 | 0.152 | 0.039 | TRPM8 blocker | 0.039 0.026 CID_252325 | CID_252325 | |
| 0.005 | 0.148 | 0.026 | Prostaglandin EP2 agonist | 0.026 0.014 CID_252325 | CID_252325 | |
| 0.044 | 0.193 | 0.161 | HIV-1 integrase (Overall Integration) inhibitor | 0.161 0.021 CID_252325 0.117 0.041 CID_173322 | CID_252325 | |
| 0.009 | 0.158 | 0.035 | CYP24 inhibitor | 0.035 0.008 CID_252325 | CID_252325 | |
| 0.003 | 0.152 | 0.019 | Integrin beta2 antagonist | 0.019 0.005 CID_252325 | CID_252325 | |
| 0.009 | 0.161 | 0.045 | LFA antagonist | 0.045 0.006 CID_252325 | CID_252325 | |
| 0.011 | 0.162 | 0.03 | Epoxide hydrolase 1 inhibitor | 0.03 0.024 CID_173322 | CID_173322 | |
| 0.024 | 0.179 | 0.057 | Androgen agonist | 0.057 0.045 CID_252325 | CID_252325 | |
| 0.007 | 0.163 | 0.078 | Histone deacetylase 5 inhibitor | 0.078 0.012 CID_252325 | CID_252325 | |
| 0.014 | 0.17 | 0.11 | Prostaglandin EP2 antagonist | 0.11 0.016 CID_252325 | CID_252325 | |
| 0.025 | 0.186 | 0.066 | Heparanase inhibitor | 0.066 0.015 CID_252325 | CID_252325 | |
| 0.047 | 0.21 | 0.198 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.198 0.016 CID_252325 0.157 0.024 CID_173322 | CID_252325 | |
| 0.029 | 0.192 | 0.086 | Dihydroorotate oxidase inhibitor | 0.086 0.008 CID_252325 0.062 0.026 CID_173322 | CID_252325 | |
| 0.077 | 0.241 | 0.127 | Heat shock protein 90 alpha antagonist | 0.127 0.116 CID_252325 | CID_252325 | |
| 0.023 | 0.189 | 0.194 | Catalase inhibitor | 0.194 0.016 CID_252325 | CID_252325 | |
| 0.046 | 0.212 | 0.169 | Triose-phosphate isomerase inhibitor | 0.169 0.015 CID_252325 0.12 0.032 CID_173322 | CID_252325 | |
| 0.032 | 0.198 | 0.216 | Monophenol monooxygenase inhibitor | 0.216 0.03 CID_252325 | CID_252325 | |
| 0.017 | 0.184 | 0.064 | Retinoid X receptor antagonist | 0.064 0.005 CID_252325 | CID_252325 | |
| 0.046 | 0.213 | 0.089 | GABA B receptor agonist | 0.074 0.057 CID_252325 0.089 0.028 CID_173322 | CID_173322 | |
| 0.025 | 0.194 | 0.119 | Nicotinic alpha4beta2 receptor antagonist | 0.119 0.018 CID_252325 | CID_252325 | |
| 0.12 | 0.29 | 0.225 | RNA-directed DNA polymerase inhibitor | 0.224 0.069 CID_252325 0.225 0.069 CID_173322 | CID_173322 | |
| 0.007 | 0.177 | 0.038 | Sirtuin 2 inhibitor | 0.038 0.019 CID_252325 | CID_252325 | |
| 0.043 | 0.215 | 0.196 | UDP-glucose 4-epimerase inhibitor | 0.196 0.019 CID_252325 0.13 0.037 CID_173322 | CID_252325 | |
| 0.076 | 0.248 | 0.138 | Dual specificity phosphatase inhibitor | 0.138 0.109 CID_173322 | CID_173322 | |
| 0.026 | 0.198 | 0.097 | Na+ K+ transporting ATPase inhibitor | 0.097 0.035 CID_252325 | CID_252325 | |
| 0.043 | 0.216 | 0.189 | Cholesterol synthesis inhibitor | 0.189 0.03 CID_252325 | CID_252325 | |
| 0.016 | 0.191 | 0.055 | Retinoid X alpha receptor antagonist | 0.055 0.005 CID_252325 | CID_252325 | |
| 0.076 | 0.252 | 0.608 | Interleukin antagonist | 0.608 0.011 CID_252325 | CID_252325 | |
| 0.137 | 0.315 | 0.46 | Histamine release inhibitor | 0.46 0.045 CID_252325 0.278 0.136 CID_173322 | CID_252325 | |
| 0.018 | 0.198 | 0.093 | Prostaglandin-E synthase inhibitor | 0.093 0.031 CID_252325 | CID_252325 | |
| 0.124 | 0.313 | 0.239 | Nitric-oxide synthase stimulant | 0.239 0.041 CID_252325 0.18 0.128 CID_173322 | CID_252325 | |
| 0.03 | 0.22 | 0.11 | Potassium channel (Ca-activated) activator | 0.087 0.068 CID_252325 0.11 0.048 CID_173322 | CID_173322 | |
| 0.016 | 0.208 | 0.163 | Antineoplastic antibiotic | 0.163 0.028 CID_252325 | CID_252325 | |
| 0.008 | 0.201 | 0.035 | Histone deacetylase 2 inhibitor | 0.035 0.022 CID_252325 | CID_252325 | |
| 0.147 | 0.341 | 0.252 | MAP kinase kinase 3 inhibitor | 0.252 0.03 CID_252325 | CID_252325 | |
| 0.036 | 0.231 | 0.063 | Lipocortins synthesis agonist | 0.063 0.03 CID_252325 | CID_252325 | |
| 0.082 | 0.278 | 0.212 | 3C-like protease (Human coronavirus) inhibitor | 0.212 0.045 CID_252325 | CID_252325 | |
| 0.011 | 0.208 | 0.046 | Cyclophilin A inhibitor | 0.046 0.008 CID_252325 | CID_252325 | |
| 0.011 | 0.21 | 0.066 | NMDA 2C receptor antagonist | 0.066 0.037 CID_173322 | CID_173322 | |
| 0.018 | 0.22 | 0.128 | Carbonic anhydrase V inhibitor | 0.128 0.02 CID_252325 | CID_252325 | |
| 0.007 | 0.209 | 0.053 | Histone deacetylase class IIa inhibitor | 0.053 0.013 CID_252325 | CID_252325 | |
| 0.034 | 0.237 | 0.119 | Urease inhibitor | 0.119 0.046 CID_252325 0.098 0.069 CID_173322 | CID_252325 | |
| 0.006 | 0.213 | 0.031 | Histone deacetylase 10 inhibitor | 0.031 0.02 CID_252325 | CID_252325 | |
| 0.054 | 0.261 | 0.201 | Aldehyde dehydrogenase inhibitor | 0.201 0.027 CID_252325 0.104 0.091 CID_173322 | CID_252325 | |
| 0.009 | 0.216 | 0.035 | Nicotinic acid receptor 2 agonist | 0.035 0.026 CID_252325 | CID_252325 | |
| 0.027 | 0.236 | 0.079 | Pregnane X receptor antagonist | 0.079 0.007 CID_252325 | CID_252325 | |
| 0.134 | 0.345 | 0.387 | Interleukin 2 agonist | 0.387 0.031 CID_252325 0.208 0.176 CID_173322 | CID_252325 | |
| 0.028 | 0.239 | 0.068 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.068 0.03 CID_252325 | CID_252325 | |
| 0.017 | 0.229 | 0.045 | AICAR transformylase inhibitor | 0.045 0.029 CID_173322 | CID_173322 | |
| 0.031 | 0.247 | 0.058 | Adenine nucleotide translocase inhibitor | 0.058 0.033 CID_173322 | CID_173322 | |
| 0.096 | 0.315 | 0.192 | Histone acetyltransferase inhibitor | 0.186 0.091 CID_10003684 0.192 0.081 CID_252325 | CID_252325 | |
| 0.009 | 0.231 | 0.045 | Angiotensin AT1 receptor antagonist | 0.045 0.025 CID_252325 | CID_252325 | |
| 0.009 | 0.231 | 0.033 | ICAM 1 antagonist | 0.033 0.005 CID_252325 | CID_252325 | |
| 0.027 | 0.249 | 0.159 | Protease 3C (Human rhinovirus) inhibitor | 0.159 0.006 CID_252325 | CID_252325 | |
| 0.035 | 0.257 | 0.133 | Sphingomyelinase inhibitor | 0.133 0.033 CID_252325 | CID_252325 | |
| 0.073 | 0.296 | 0.196 | Vanilloid 1 agonist | 0.196 0.013 CID_252325 | CID_252325 | |
| 0.048 | 0.273 | 0.177 | Carbonic anhydrase XV inhibitor | 0.177 0.023 CID_252325 | CID_252325 | |
| 0.049 | 0.274 | 0.097 | D-Ala-D-Ala ligase inhibitor | 0.097 0.034 CID_252325 0.095 0.035 CID_173322 | CID_252325 | |
| 0.043 | 0.268 | 0.153 | Caspase 3 inhibitor | 0.153 0.026 CID_252325 | CID_252325 | |
| 0.103 | 0.331 | 0.457 | Immunosuppressant | 0.227 0.169 CID_10003684 0.457 0.045 CID_252325 | CID_252325 | |
| 0.005 | 0.235 | 0.044 | Prostaglandin agonist | 0.044 0.012 CID_252325 | CID_252325 | |
| 0.014 | 0.244 | 0.062 | Lysophosphatidic acid 3 receptor antagonist | 0.062 0.021 CID_252325 | CID_252325 | |
| 0.013 | 0.246 | 0.054 | Dihydrofolate reductase inhibitor | 0.054 0.015 CID_252325 | CID_252325 | |
| 0.009 | 0.242 | 0.115 | Carbonic anhydrase VB inhibitor | 0.115 0.013 CID_252325 | CID_252325 | |
| 0.008 | 0.245 | 0.043 | Peroxisome proliferator-activated receptor alpha agonist | 0.043 0.039 CID_252325 | CID_252325 | |
| 0.015 | 0.253 | 0.051 | Protein 50S ribosomal subunit inhibitor | 0.051 0.039 CID_252325 | CID_252325 | |
| 0.013 | 0.251 | 0.144 | Alcohol oxidase inhibitor | 0.144 0.011 CID_252325 0.069 0.029 CID_173322 | CID_252325 | |
| 0.025 | 0.263 | 0.107 | Purinergic P2X1 antagonist | 0.107 0.014 CID_252325 0.058 0.046 CID_173322 | CID_252325 | |
| 0.016 | 0.254 | 0.054 | Alpha-mannosidase inhibitor | 0.054 0.035 CID_252325 | CID_252325 | |
| 0.021 | 0.259 | 0.051 | Integrin alpha1beta1 antagonist | 0.051 0.007 CID_252325 | CID_252325 | |
| 0.047 | 0.285 | 0.092 | Nav1.1 sodium channel blocker | 0.092 0.076 CID_252325 | CID_252325 | |
| 0.019 | 0.258 | 0.119 | Carbonic anhydrase VA inhibitor | 0.119 0.018 CID_252325 | CID_252325 | |
| 0.096 | 0.336 | 0.269 | Gastrin inhibitor | 0.269 0.059 CID_252325 0.226 0.11 CID_173322 | CID_252325 | |
| 0.01 | 0.251 | 0.032 | Angiotensin II receptor antagonist | 0.032 0.028 CID_252325 | CID_252325 | |
| 0.039 | 0.281 | 0.174 | GABA C receptor rho-1 antagonist | 0.174 0.013 CID_252325 0.095 0.07 CID_173322 | CID_252325 | |
| 0.009 | 0.25 | 0.039 | Histone deacetylase class IV inhibitor | 0.039 0.017 CID_252325 | CID_252325 | |
| 0.009 | 0.25 | 0.039 | Histone deacetylase 11 inhibitor | 0.039 0.017 CID_252325 | CID_252325 | |
| 0.006 | 0.248 | 0.025 | Protease (Human cytomegalovirus) inhibitor | 0.025 0.011 CID_252325 | CID_252325 | |
| 0.007 | 0.251 | 0.068 | Nicotinic acid receptor 2 antagonist | 0.068 0.003 CID_252325 | CID_252325 | |
| 0.008 | 0.253 | 0.028 | Acid ceramidase inhibitor | 0.028 0.013 CID_252325 | CID_252325 | |
| 0.047 | 0.297 | 0.242 | Cytokine production inhibitor | 0.107 0.104 CID_10003684 0.242 0.025 CID_252325 | CID_252325 | |
| 0.008 | 0.258 | 0.03 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 CID_252325 | CID_252325 | |
| 0.034 | 0.288 | 0.137 | Anabolic | 0.137 0.026 CID_252325 | CID_252325 | |
| 0.048 | 0.302 | 0.149 | Estrogen antagonist | 0.149 0.024 CID_252325 | CID_252325 | |
| 0.041 | 0.3 | 0.166 | Lanosterol 14 alpha demethylase inhibitor | 0.166 0.007 CID_252325 | CID_252325 | |
| 0.008 | 0.267 | 0.032 | ATP citrate lysase inhibitor | 0.032 0.021 CID_252325 | CID_252325 | |
| 0.034 | 0.294 | 0.192 | GABA C receptor antagonist | 0.192 0.014 CID_252325 0.098 0.082 CID_173322 | CID_252325 | |
| 0.1 | 0.361 | 0.193 | Ca2+-transporting ATPase inhibitor | 0.193 0.004 CID_252325 0.131 0.113 CID_173322 | CID_252325 | |
| 0.107 | 0.368 | 0.271 | Sodium/bile acid cotransporter inhibitor | 0.266 0.111 CID_252325 0.271 0.106 CID_173322 | CID_173322 | |
| 0.005 | 0.267 | 0.047 | Methionyl aminopeptidase 1 inhibitor | 0.047 0.008 CID_252325 | CID_252325 | |
| 0.004 | 0.266 | 0.017 | Vitamin D receptor agonist | 0.017 0.011 CID_252325 | CID_252325 | |
| 0.003 | 0.265 | 0.03 | Prostaglandin E2 agonist | 0.03 0.011 CID_252325 | CID_252325 | |
| 0.026 | 0.289 | 0.081 | Interferon agonist | 0.081 0.05 CID_252325 | CID_252325 | |
| 0.003 | 0.267 | 0.018 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.018 0.015 CID_252325 | CID_252325 | |
| 0.011 | 0.276 | 0.047 | Histamine H2 receptor agonist | 0.047 0.025 CID_252325 | CID_252325 | |
| 0.01 | 0.274 | 0.049 | Glycine transporter 2 inhibitor | 0.049 0.031 CID_252325 | CID_252325 | |
| 0.109 | 0.373 | 0.228 | ErbB-1 antagonist | 0.228 0.065 CID_252325 | CID_252325 | |
| 0.006 | 0.271 | 0.099 | Estrogen agonist | 0.099 0.018 CID_252325 | CID_252325 | |
| 0.011 | 0.277 | 0.042 | Mannosidase inhibitor | 0.042 0.037 CID_252325 | CID_252325 | |
| 0.016 | 0.284 | 0.111 | Aconitate hydratase inhibitor | 0.111 0.007 CID_252325 | CID_252325 | |
| 0.021 | 0.292 | 0.084 | Fatty acid synthase inhibitor | 0.084 0.016 CID_252325 | CID_252325 | |
| 0.012 | 0.284 | 0.12 | Phosphofructokinase-1 inhibitor | 0.12 0.025 CID_252325 | CID_252325 | |
| 0.007 | 0.28 | 0.06 | Ornithine carbamoyltransferase inhibitor | 0.06 0.032 CID_252325 | CID_252325 | |
| 0.001 | 0.277 | 0.016 | Lysophosphatidic acid receptor 3 agonist | 0.016 0.007 CID_252325 | CID_252325 | |
| 0.038 | 0.314 | 0.065 | Calcium channel P-type blocker | 0.065 0.039 CID_252325 | CID_252325 | |
| 0.047 | 0.324 | 0.153 | Acetylcholine release stimulant | 0.153 0.014 CID_252325 | CID_252325 | |
| 0.029 | 0.307 | 0.07 | Peroxisome proliferator-activated receptor gamma antagonist | 0.07 0.053 CID_252325 | CID_252325 | |
| 0.075 | 0.354 | 0.19 | Papain-like protease (SARS coronavirus) inhibitor | 0.19 0.013 CID_252325 | CID_252325 | |
| 0.05 | 0.331 | 0.246 | Insulin sensitizer | 0.246 0.036 CID_252325 | CID_252325 | |
| 0.006 | 0.288 | 0.034 | Neuraminidase (Influenza B) inhibitor | 0.034 0.004 CID_252325 | CID_252325 | |
| 0.016 | 0.298 | 0.207 | Porphobilinogen synthase inhibitor | 0.207 0.011 CID_252325 0.101 0.035 CID_173322 | CID_252325 | |
| 0.05 | 0.333 | 0.23 | Arachidonic acid antagonist | 0.23 0.012 CID_252325 | CID_252325 | |
| 0.016 | 0.301 | 0.035 | Adenosine uptake inhibitor | 0.035 0.023 CID_252325 | CID_252325 | |
| 0.025 | 0.311 | 0.088 | Potassium channel (Tandem pore domain) blocker | 0.088 0.02 CID_252325 | CID_252325 | |
| 0.063 | 0.349 | 0.209 | Calpain inhibitor | 0.209 0.105 CID_252325 | CID_252325 | |
| 0.108 | 0.395 | 0.563 | GABA C receptor rho-3 antagonist | 0.563 0.012 CID_252325 | CID_252325 | |
| 0.016 | 0.305 | 0.053 | Potassium channel Kv1.1 blocker | 0.053 0.011 CID_252325 | CID_252325 | |
| 0.088 | 0.378 | 0.199 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.192 0.08 CID_252325 0.199 0.073 CID_173322 | CID_173322 | |
| 0.004 | 0.294 | 0.021 | Histone deacetylase 3 inhibitor | 0.021 0.019 CID_252325 | CID_252325 | |
| 0.02 | 0.31 | 0.068 | Topoisomerase II alpha inhibitor | 0.068 0.063 CID_252325 | CID_252325 | |
| 0.039 | 0.33 | 0.243 | Cyclooxygenase inhibitor | 0.243 0.028 CID_252325 | CID_252325 | |
| 0.032 | 0.324 | 0.209 | Cyclooxygenase 2 inhibitor | 0.209 0.028 CID_252325 | CID_252325 | |
| 0.005 | 0.298 | 0.119 | Protease activated receptor 1 antagonist | 0.119 0.011 CID_252325 | CID_252325 | |
| 0.005 | 0.299 | 0.03 | Leukotriene D4 antagonist | 0.03 0.015 CID_252325 | CID_252325 | |
| 0.008 | 0.303 | 0.046 | Leukocyte elastase inhibitor | 0.046 0.027 CID_252325 | CID_252325 | |
| 0.055 | 0.351 | 0.202 | Antiamyloidogenic | 0.202 0.098 CID_252325 | CID_252325 | |
| 0.005 | 0.301 | 0.035 | Histone deacetylase 1 inhibitor | 0.035 0.014 CID_252325 | CID_252325 | |
| 0.006 | 0.302 | 0.024 | CXC chemokine 5 receptor antagonist | 0.024 0.005 CID_252325 | CID_252325 | |
| 0.005 | 0.301 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.021 CID_252325 | CID_252325 | |
| 0.019 | 0.316 | 0.071 | Potassium channel (ATP-sensitive) blocker | 0.071 0.039 CID_252325 | CID_252325 | |
| 0.005 | 0.303 | 0.03 | Histone deacetylase 4 inhibitor | 0.03 0.024 CID_252325 | CID_252325 | |
| 0.023 | 0.321 | 0.082 | HIV-1 integrase inhibitor | 0.063 0.06 CID_10003684 0.082 0.036 CID_252325 | CID_252325 | |
| 0.028 | 0.329 | 0.248 | Cystathionine beta-synthase inhibitor | 0.248 0.015 CID_252325 | CID_252325 | |
| 0.012 | 0.314 | 0.086 | Leukotriene antagonist | 0.086 0.028 CID_252325 | CID_252325 | |
| 0.009 | 0.311 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.02 CID_252325 | CID_252325 | |
| 0.04 | 0.343 | 0.122 | Antibacterial (Helicobacter pylori) | 0.122 0.078 CID_252325 | CID_252325 | |
| 0.031 | 0.338 | 0.34 | Cyclooxygenase 1 inhibitor | 0.34 0.01 CID_252325 | CID_252325 | |
| 0.026 | 0.335 | 0.072 | Leukotriene C antagonist | 0.072 0.012 CID_252325 | CID_252325 | |
| 0.005 | 0.315 | 0.057 | Fumarate hydratase inhibitor | 0.057 0.011 CID_252325 | CID_252325 | |
| 0.011 | 0.324 | 0.031 | Complement factor 1s inhibitor | 0.031 0.007 CID_252325 | CID_252325 | |
| 0.057 | 0.371 | 0.117 | Interleukin 2 antagonist | 0.117 0.05 CID_252325 | CID_252325 | |
| 0.003 | 0.318 | 0.034 | Uridine phosphorylase inhibitor | 0.034 0.015 CID_252325 | CID_252325 | |
| 0.026 | 0.34 | 0.106 | Gastric antisecretory | 0.106 0.058 CID_252325 | CID_252325 | |
| 0.01 | 0.326 | 0.054 | Factor XIIIa inhibitor | 0.054 0.014 CID_252325 | CID_252325 | |
| 0.036 | 0.353 | 0.222 | Pyruvate kinase inhibitor | 0.142 0.122 CID_10003684 0.222 0.07 CID_252325 | CID_252325 | |
| 0.083 | 0.4 | 0.291 | Neuropeptide Y2 antagonist | 0.291 0.023 CID_252325 | CID_252325 | |
| 0.034 | 0.352 | 0.167 | Proteasome inhibitor | 0.167 0.037 CID_252325 | CID_252325 | |
| 0.009 | 0.328 | 0.041 | Nerve growth factor antagonist | 0.039 0.038 CID_252325 0.041 0.034 CID_173322 | CID_173322 | |
| 0.007 | 0.329 | 0.035 | Inosine monophosphate dehydrogenase inhibitor | 0.035 0.026 CID_252325 | CID_252325 | |
| 0.072 | 0.397 | 0.268 | DNA synthesis inhibitor | 0.268 0.056 CID_252325 0.221 0.094 CID_173322 | CID_252325 | |
| 0.06 | 0.387 | 0.221 | Tumour necrosis factor antagonist | 0.221 0.042 CID_252325 | CID_252325 | |
| 0.004 | 0.332 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 CID_252325 | CID_252325 | |
| 0.01 | 0.339 | 0.065 | Membrane dipeptidase inhibitor | 0.065 0.009 CID_252325 | CID_252325 | |
| 0.004 | 0.334 | 0.052 | Prostaglandin EP3 antagonist | 0.052 0.009 CID_252325 | CID_252325 | |
| 0.01 | 0.341 | 0.049 | CC chemokine 2 receptor antagonist | 0.049 0.048 CID_252325 | CID_252325 | |
| 0.002 | 0.334 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 CID_252325 | CID_252325 | |
| 0.025 | 0.357 | 0.057 | Ryanodine receptor antagonist | 0.057 0.046 CID_252325 | CID_252325 | |
| 0.01 | 0.342 | 0.087 | Argininosuccinate synthase inhibitor | 0.087 0.023 CID_252325 | CID_252325 | |
| 0.004 | 0.336 | 0.048 | Methionyl aminopeptidase 2 inhibitor | 0.048 0.007 CID_252325 | CID_252325 | |
| 0.01 | 0.343 | 0.055 | Histone deacetylase 9 inhibitor | 0.055 0.013 CID_252325 | CID_252325 | |
| 0.011 | 0.347 | 0.058 | Leukotriene B4 antagonist | 0.058 0.031 CID_252325 | CID_252325 | |
| 0.039 | 0.375 | 0.23 | Cell wall synthesis inhibitor | 0.23 0.02 CID_252325 | CID_252325 | |
| 0.008 | 0.346 | 0.067 | Histone deacetylase 7 inhibitor | 0.067 0.014 CID_252325 | CID_252325 | |
| 0.024 | 0.364 | 0.121 | Glutamate dehydrogenase inhibitor | 0.121 0.022 CID_252325 | CID_252325 | |
| 0.069 | 0.409 | 0.16 | Sphingosine 1-phosphate receptor 5 antagonist | 0.16 0.046 CID_252325 0.133 0.093 CID_173322 | CID_252325 | |
| 0.021 | 0.362 | 0.069 | Macrophage migration inhibitory factor inhibitor | 0.069 0.068 CID_252325 | CID_252325 | |
| 0.005 | 0.351 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.015 CID_252325 | CID_252325 | |
| 0.087 | 0.433 | 0.315 | Insulysin inhibitor | 0.315 0.05 CID_252325 | CID_252325 | |
| 0.01 | 0.357 | 0.041 | Thrombin receptor antagonist | 0.041 0.011 CID_252325 | CID_252325 | |
| 0.017 | 0.364 | 0.106 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.106 0.01 CID_252325 | CID_252325 | |
| 0.003 | 0.35 | 0.036 | Estrogen receptor alpha agonist | 0.036 0.023 CID_252325 | CID_252325 | |
| 0.016 | 0.366 | 0.049 | Leukotriene C4 antagonist | 0.049 0.011 CID_252325 | CID_252325 | |
| 0.036 | 0.388 | 0.116 | Acetylcholine M1 receptor antagonist | 0.116 0.114 CID_252325 | CID_252325 | |
| 0.004 | 0.359 | 0.03 | Imidazoline I1 receptor antagonist | 0.03 0.007 CID_252325 | CID_252325 | |
| 0.018 | 0.374 | 0.064 | Cathepsin G inhibitor | 0.064 0.062 CID_252325 | CID_252325 | |
| 0.011 | 0.367 | 0.068 | Protein kinase C theta inhibitor | 0.068 0.025 CID_252325 | CID_252325 | |
| 0.002 | 0.359 | 0.024 | Prostaglandin H2 antagonist | 0.024 0.019 CID_252325 | CID_252325 | |
| 0.014 | 0.376 | 0.069 | Metalloproteinase-9 inhibitor | 0.069 0.057 CID_252325 | CID_252325 | |
| 0.053 | 0.417 | 0.109 | DNA repair enzyme inhibitor | 0.109 0.099 CID_252325 | CID_252325 | |
| 0.005 | 0.368 | 0.057 | Guanylate cyclase inhibitor | 0.057 0.014 CID_252325 | CID_252325 | |
| 0.023 | 0.389 | 0.138 | Aminopeptidase B inhibitor | 0.138 0.043 CID_252325 | CID_252325 | |
| 0.012 | 0.382 | 0.105 | Adenylate cyclase 1 inhibitor | 0.105 0.004 CID_252325 | CID_252325 | |
| 0.025 | 0.399 | 0.105 | Glycine receptor agonist | 0.105 0.018 CID_252325 | CID_252325 | |
| 0.026 | 0.401 | 0.12 | Estrogen receptor beta antagonist | 0.12 0.032 CID_252325 | CID_252325 | |
| 0.014 | 0.389 | 0.204 | Inducible nitric-oxide synthase inhibitor | 0.204 0.008 CID_252325 | CID_252325 | |
| 0.038 | 0.416 | 0.412 | Hypolipemic | 0.163 0.124 CID_10003684 0.412 0.023 CID_252325 | CID_252325 | |
| 0.016 | 0.4 | 0.094 | Alcohol dehydrogenase inhibitor | 0.094 0.059 CID_252325 | CID_252325 | |
| 0.006 | 0.39 | 0.049 | Alpha 1d adrenoreceptor agonist | 0.049 0.017 CID_252325 | CID_252325 | |
| 0.001 | 0.387 | 0.016 | Carbonic anhydrase X inhibitor | 0.016 0.012 CID_252325 | CID_252325 | |
| 0.001 | 0.387 | 0.016 | Carbonic anhydrase VIII inhibitor | 0.016 0.012 CID_252325 | CID_252325 | |
| 0.044 | 0.431 | 0.108 | Glutamate release inhibitor | 0.108 0.032 CID_252325 | CID_252325 | |
| 0.01 | 0.397 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.02 CID_252325 | CID_252325 | |
| 0.04 | 0.427 | 0.105 | Estrogen-related receptor beta agonist | 0.105 0.019 CID_252325 | CID_252325 | |
| 0.045 | 0.431 | 0.149 | Hexokinase inhibitor | 0.149 0.08 CID_252325 0.142 0.089 CID_173322 | CID_252325 | |
| 0.005 | 0.398 | 0.025 | Prostaglandin F2 alpha agonist | 0.025 0.013 CID_252325 | CID_252325 | |
| 0.01 | 0.404 | 0.032 | Melatonin receptor 1A agonist | 0.032 0.027 CID_252325 | CID_252325 | |
| 0.003 | 0.4 | 0.037 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.037 0.018 CID_252325 | CID_252325 | |
| 0.037 | 0.435 | 0.345 | Peroxidase inhibitor | 0.345 0.029 CID_252325 | CID_252325 | |
| 0.021 | 0.424 | 0.169 | ATPase (Vacuolar H+) inhibitor | 0.169 0.004 CID_252325 | CID_252325 | |
| 0.005 | 0.408 | 0.043 | Histone deacetylase class II inhibitor | 0.043 0.013 CID_252325 | CID_252325 | |
| 0.048 | 0.452 | 0.197 | Adenylate cyclase stimulant | 0.197 0.015 CID_252325 | CID_252325 | |
| 0.025 | 0.431 | 0.112 | Estrogen receptor alpha antagonist | 0.112 0.021 CID_252325 | CID_252325 | |
| 0.007 | 0.413 | 0.035 | Thymidine phosphorylase inhibitor | 0.035 0.008 CID_252325 | CID_252325 | |
| 0.008 | 0.417 | 0.057 | Prolyl endopeptidase inhibitor | 0.057 0.027 CID_252325 | CID_252325 | |
| 0.013 | 0.425 | 0.072 | Glucose-6-phosphate isomerase inhibitor | 0.072 0.011 CID_252325 | CID_252325 | |
| 0.134 | 0.549 | 0.471 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.471 0.048 CID_252325 0.319 0.188 CID_173322 | CID_252325 | |
| 0.013 | 0.429 | 0.052 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.052 0.012 CID_252325 | CID_252325 | |
| 0.021 | 0.438 | 0.08 | Histamine H2 receptor antagonist | 0.08 0.065 CID_252325 | CID_252325 | |
| 0.003 | 0.422 | 0.027 | Nicotinic alpha4beta2 receptor agonist | 0.027 0.022 CID_252325 | CID_252325 | |
| 0.088 | 0.514 | 0.421 | Tyrosine 3 hydroxylase inhibitor | 0.421 0.006 CID_252325 | CID_252325 | |
| 0.001 | 0.428 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.006 CID_252325 | CID_252325 | |
| 0.002 | 0.439 | 0.017 | Telomerase stimulant | 0.017 0.012 CID_252325 | CID_252325 | |
| 0.012 | 0.452 | 0.202 | Expectorant | 0.202 0.02 CID_252325 | CID_252325 | |
| 0.019 | 0.46 | 0.339 | Ferrochelatase inhibitor | 0.339 0.005 CID_252325 0.089 0.084 CID_173322 | CID_252325 | |
| 0.001 | 0.443 | 0.012 | Imidazoline I2 receptor antagonist | 0.012 0.006 CID_252325 | CID_252325 | |
| 0.024 | 0.468 | 0.427 | Alpha-N-acetylglucosaminidase inhibitor | 0.427 0.008 CID_252325 | CID_252325 | |
| 0.008 | 0.453 | 0.032 | Estrogen-related receptor gamma antagonist | 0.032 0.013 CID_252325 | CID_252325 | |
| 0.03 | 0.477 | 0.111 | Vanilloid agonist | 0.111 0.023 CID_252325 | CID_252325 | |
| 0.005 | 0.454 | 0.061 | Dopamine D5 agonist | 0.061 0.011 CID_252325 | CID_252325 | |
| 0.009 | 0.459 | 0.065 | Neuraminidase (Influenza A) inhibitor | 0.065 0.009 CID_252325 | CID_252325 | |
| 0.021 | 0.472 | 0.162 | Exportin-1 inhibitor | 0.162 0.003 CID_252325 | CID_252325 | |
| 0.01 | 0.461 | 0.117 | Glutamate decarboxylase inhibitor | 0.117 0.022 CID_252325 | CID_252325 | |
| 0.048 | 0.5 | 0.197 | Angiogenesis inhibitor | 0.197 0.173 CID_252325 | CID_252325 | |
| 0.018 | 0.47 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.041 CID_252325 | CID_252325 | |
| 0.005 | 0.458 | 0.077 | Protease activated receptor antagonist | 0.077 0.026 CID_252325 | CID_252325 | |
| 0.019 | 0.477 | 0.171 | Prolactin inhibitor | 0.171 0.015 CID_252325 | CID_252325 | |
| 0.099 | 0.557 | 0.289 | 5 Hydroxytryptamine 3E antagonist | 0.289 0.006 CID_252325 | CID_252325 | |
| 0.011 | 0.473 | 0.159 | CYP2A6 inhibitor | 0.159 0.014 CID_252325 | CID_252325 | |
| 0.028 | 0.49 | 0.137 | Adenylate cyclase inhibitor | 0.137 0.054 CID_252325 | CID_252325 | |
| 0.027 | 0.491 | 0.097 | Alpha 2d adrenoreceptor antagonist | 0.097 0.055 CID_252325 | CID_252325 | |
| 0.016 | 0.481 | 0.085 | Histamine N-methyltransferase inhibitor | 0.085 0.061 CID_252325 | CID_252325 | |
| 0.014 | 0.484 | 0.084 | Glutamate (mGluR7) antagonist | 0.084 0.023 CID_252325 | CID_252325 | |
| 0.018 | 0.495 | 0.272 | GABA C receptor agonist | 0.272 0.011 CID_252325 | CID_252325 | |
| 0.011 | 0.492 | 0.105 | Potassium channel (Voltage-sensitive) activator | 0.105 0.047 CID_252325 | CID_252325 | |
| 0.013 | 0.496 | 0.179 | Protein kinase C delta inhibitor | 0.179 0.012 CID_252325 | CID_252325 | |
| 0.022 | 0.504 | 0.108 | Beta amyloid protein antagonist | 0.108 0.079 CID_252325 | CID_252325 | |
| 0.004 | 0.487 | 0.045 | Histone deacetylase class I inhibitor | 0.045 0.023 CID_252325 | CID_252325 | |
| 0.01 | 0.494 | 0.038 | Thymidine kinase inhibitor | 0.038 0.034 CID_252325 | CID_252325 | |
| 0.005 | 0.494 | 0.073 | Prostaglandin E2 antagonist | 0.073 0.022 CID_252325 | CID_252325 | |
| 0.006 | 0.497 | 0.034 | Melanocortin 1 antagonist | 0.034 0.03 CID_252325 | CID_252325 | |
| 0.023 | 0.517 | 0.06 | Immunoglobulin Fc receptor antagonist | 0.06 0.025 CID_252325 | CID_252325 | |
| 0.014 | 0.51 | 0.178 | Nitric-oxide synthase inhibitor | 0.178 0.014 CID_252325 | CID_252325 | |
| 0.005 | 0.506 | 0.028 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.025 CID_252325 | CID_252325 | |
| 0.017 | 0.519 | 0.096 | Interleukin 1 beta converting enzyme inhibitor | 0.096 0.063 CID_252325 | CID_252325 | |
| 0.002 | 0.506 | 0.017 | Alpha 2c adrenoreceptor agonist | 0.017 0.015 CID_252325 | CID_252325 | |
| 0.005 | 0.51 | 0.029 | Vanilloid 2 agonist | 0.029 0.012 CID_252325 | CID_252325 | |
| 0.013 | 0.52 | 0.061 | Prostaglandin F2 alpha antagonist | 0.061 0.045 CID_252325 | CID_252325 | |
| 0.004 | 0.513 | 0.036 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.036 0.028 CID_252325 | CID_252325 | |
| 0.015 | 0.529 | 0.164 | Creatine kinase inhibitor | 0.164 0.019 CID_252325 | CID_252325 | |
| 0.017 | 0.532 | 0.092 | AMP-activated protein kinase stimulant | 0.092 0.083 CID_252325 | CID_252325 | |
| 0.016 | 0.533 | 0.043 | Heme oxygenase inhibitor | 0.043 0.029 CID_252325 | CID_252325 | |
| 0.009 | 0.532 | 0.082 | Histone deacetylase inhibitor | 0.082 0.029 CID_252325 | CID_252325 | |
| 0.009 | 0.535 | 0.075 | Secretase beta inhibitor | 0.075 0.043 CID_252325 | CID_252325 | |
| 0.023 | 0.549 | 0.141 | NADH dehydrogenase inhibitor | 0.141 0.02 CID_252325 | CID_252325 | |
| 0.004 | 0.532 | 0.053 | Histone deacetylase 8 inhibitor | 0.053 0.02 CID_252325 | CID_252325 | |
| 0.013 | 0.54 | 0.069 | 5 Hydroxytryptamine 3 agonist | 0.069 0.037 CID_252325 | CID_252325 | |
| 0.005 | 0.535 | 0.156 | Acyl-CoA dehydrogenase inhibitor | 0.156 0.009 CID_252325 | CID_252325 | |
| 0.012 | 0.542 | 0.128 | Mucolytic | 0.128 0.047 CID_252325 | CID_252325 | |
| 0.008 | 0.538 | 0.153 | Phenylalanine 4-hydroxylase inhibitor | 0.153 0.011 CID_252325 | CID_252325 | |
| 0.01 | 0.541 | 0.051 | Lysine-specific demethylase 1A inhibitor | 0.051 0.044 CID_252325 | CID_252325 | |
| 0.034 | 0.577 | 0.157 | Transcription factor STAT6 inhibitor | 0.157 0.019 CID_252325 | CID_252325 | |
| 0.003 | 0.553 | 0.019 | Alpha 2b adrenoreceptor agonist | 0.019 0.012 CID_252325 | CID_252325 | |
| 0.028 | 0.584 | 0.428 | Tumour necrosis factor alpha release inhibitor | 0.428 0.022 CID_252325 | CID_252325 | |
| 0.021 | 0.58 | 0.103 | Nav1.3 sodium channel blocker | 0.103 0.094 CID_252325 | CID_252325 | |
| 0.003 | 0.565 | 0.053 | Prostaglandin EP4 antagonist | 0.053 0.008 CID_252325 | CID_252325 | |
| 0.021 | 0.587 | 0.085 | MAP kinase kinase 7 inhibitor | 0.085 0.034 CID_252325 | CID_252325 | |
| 0.005 | 0.573 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.014 CID_252325 | CID_252325 | |
| 0.019 | 0.587 | 0.101 | Interleukin 8 antagonist | 0.101 0.095 CID_252325 | CID_252325 | |
| 0.007 | 0.579 | 0.093 | Aryl hydrocarbon receptor antagonist | 0.093 0.017 CID_252325 | CID_252325 | |
| 0.006 | 0.58 | 0.086 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.086 0.018 CID_252325 | CID_252325 | |
| 0.025 | 0.603 | 0.129 | Phosphodiesterase 6D inhibitor | 0.129 0.018 CID_252325 | CID_252325 | |
| 0.004 | 0.583 | 0.027 | Histone deacetylase class IIb inhibitor | 0.027 0.017 CID_252325 | CID_252325 | |
| 0.004 | 0.586 | 0.027 | Histone deacetylase 6 inhibitor | 0.027 0.017 CID_252325 | CID_252325 | |
| 0.018 | 0.6 | 0.137 | Electrolyte absorption antagonist | 0.137 0.025 CID_252325 | CID_252325 | |
| 0.004 | 0.586 | 0.034 | Delayed rectifier potassium channel activator | 0.034 0.029 CID_252325 | CID_252325 | |
| 0.004 | 0.586 | 0.034 | Potassium channel KCNQ activator | 0.034 0.029 CID_252325 | CID_252325 | |
| 0.016 | 0.601 | 0.142 | Sphingosine 1-phosphate receptor 2 antagonist | 0.142 0.052 CID_252325 | CID_252325 | |
| 0.012 | 0.602 | 0.111 | Myeloperoxidase inhibitor | 0.111 0.025 CID_252325 | CID_252325 | |
| 0.057 | 0.655 | 0.41 | 5 Hydroxytryptamine release inhibitor | 0.41 0.072 CID_252325 0.262 0.212 CID_173322 | CID_252325 | |
| 0.002 | 0.605 | 0.051 | Diamine oxidase inhibitor | 0.051 0.014 CID_252325 | CID_252325 | |
| 0.009 | 0.615 | 0.064 | Histone deacetylase SIRT3 inhibitor | 0.064 0.039 CID_252325 | CID_252325 | |
| 0.004 | 0.61 | 0.055 | 5 Hydroxytryptamine 2A agonist | 0.055 0.052 CID_252325 | CID_252325 | |
| 0.052 | 0.67 | 0.653 | 5 Hydroxytryptamine release stimulant | 0.653 0.01 CID_252325 | CID_252325 | |
| 0.004 | 0.623 | 0.092 | Amidase inhibitor | 0.092 0.029 CID_252325 | CID_252325 | |
| 0.008 | 0.626 | 0.106 | Aminopeptidase I inhibitor | 0.106 0.025 CID_252325 | CID_252325 | |
| 0.001 | 0.622 | 0.02 | Alpha 2a adrenoreceptor agonist | 0.02 0.009 CID_252325 | CID_252325 | |
| 0.008 | 0.632 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.053 0.038 CID_252325 | CID_252325 | |
| 0.073 | 0.697 | 0.383 | 5 Hydroxytryptamine uptake stimulant | 0.383 0.017 CID_252325 | CID_252325 | |
| 0.004 | 0.634 | 0.063 | Acetylcholine M5 receptor agonist | 0.063 0.051 CID_252325 | CID_252325 | |
| 0.015 | 0.653 | 0.127 | Cyclin-dependent kinase 8 inhibitor | 0.127 0.108 CID_252325 | CID_252325 | |
| 0.019 | 0.668 | 0.436 | Aldehyde oxidase inhibitor | 0.436 0.042 CID_252325 | CID_252325 | |
| 0.023 | 0.672 | 0.098 | Glutamate (mGluR7) agonist | 0.098 0.063 CID_252325 | CID_252325 | |
| 0.008 | 0.657 | 0.042 | CF transmembrane conductance regulator antagonist | 0.042 0.021 CID_252325 | CID_252325 | |
| 0.026 | 0.676 | 0.218 | Neurotrophic factor enhancer | 0.218 0.06 CID_252325 | CID_252325 | |
| 0.002 | 0.653 | 0.051 | Geranyltranstransferase inhibitor | 0.051 0.022 CID_252325 | CID_252325 | |
| 0.016 | 0.673 | 0.093 | Vanilloid 4 agonist | 0.093 0.023 CID_252325 | CID_252325 | |
| 0.004 | 0.664 | 0.049 | Histamine H1 receptor agonist | 0.049 0.02 CID_252325 | CID_252325 | |
| 0.004 | 0.665 | 0.089 | Carbamoyl phosphate synthetase inhibitor | 0.089 0.025 CID_252325 | CID_252325 | |
| 0.007 | 0.67 | 0.026 | Hedgehog signaling activator | 0.026 0.022 CID_252325 | CID_252325 | |
| 0.043 | 0.712 | 0.64 | Antiinflammatory | 0.64 0.043 CID_252325 | CID_252325 | |
| 0.013 | 0.684 | 0.072 | Phosphodiesterase VI inhibitor | 0.072 0.057 CID_252325 | CID_252325 | |
| 0.008 | 0.683 | 0.091 | Phospholipase D inhibitor | 0.091 0.021 CID_252325 | CID_252325 | |
| 0.002 | 0.678 | 0.022 | Glutamate (mGluR1a) agonist | 0.022 0.016 CID_252325 | CID_252325 | |
| 0.01 | 0.691 | 0.111 | 5 Hydroxytryptamine 3A agonist | 0.111 0.064 CID_252325 | CID_252325 | |
| 0.011 | 0.697 | 0.143 | Nav1.6 sodium channel blocker | 0.143 0.062 CID_252325 | CID_252325 | |
| 0.008 | 0.698 | 0.045 | Vanilloid 3 antagonist | 0.045 0.014 CID_252325 | CID_252325 | |
| 0.03 | 0.726 | 0.091 | CC chemokine 5 receptor agonist | 0.091 0.035 CID_252325 | CID_252325 | |
| 0.006 | 0.705 | 0.065 | Dopamine beta hydroxylase inhibitor | 0.065 0.011 CID_252325 | CID_252325 | |
| 0.001 | 0.702 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.014 0.008 CID_252325 | CID_252325 | |
| 0.014 | 0.732 | 0.093 | mTOR complex 2 inhibitor | 0.093 0.042 CID_252325 | CID_252325 | |
| 0.002 | 0.727 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.019 CID_252325 | CID_252325 | |
| 0.005 | 0.731 | 0.052 | Epithelial sodium channel blocker | 0.052 0.044 CID_252325 | CID_252325 | |
| 0.005 | 0.748 | 0.047 | Cytokine production stimulant | 0.047 0.038 CID_252325 | CID_252325 | |
| 0.003 | 0.745 | 0.05 | Cannabinoid CB2 receptor antagonist | 0.05 0.037 CID_252325 | CID_252325 | |
| 0.003 | 0.751 | 0.038 | Delayed rectifier potassium channel blocker | 0.038 0.025 CID_252325 | CID_252325 | |
| 0.006 | 0.77 | 0.101 | Polo-like kinase-1 inhibitor | 0.101 0.045 CID_252325 | CID_252325 | |
| 0.004 | 0.778 | 0.064 | Sphingosine kinase 2 inhibitor | 0.064 0.027 CID_252325 | CID_252325 | |
| 0.003 | 0.791 | 0.062 | Sphingosine kinase inhibitor | 0.062 0.036 CID_252325 | CID_252325 | |
| 0.006 | 0.795 | 0.113 | Falcipain 3 inhibitor | 0.113 0.059 CID_252325 | CID_252325 | |
| 0.002 | 0.811 | 0.037 | Oxytocin agonist | 0.037 0.035 CID_252325 | CID_252325 | |
| 0.009 | 0.824 | 0.196 | Antipruritic | 0.196 0.052 CID_252325 | CID_252325 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |